European Archives - Page 251 of 1301 - European Medical Journal

Lower Oestradiol and FSH Levels Associated with Clear Cell Renal Cancer

Lower oestradiol and FSH levels are linked to renal cell carcinoma, highlighting potential hormonal influences on tumour progression.

Postnatal Antibiotic Exposure Raises Asthma Risk in Children

A new study assessed asthma risk in children who received antibiotics in the first week of life solely due to maternal indications, eliminating infection-related bias.

Dynamic Ultrasound: A Game-Changer in Diagnosing Peroneal Tendon Instability: ECR 2025

New research from ECR 2025 shows promise in using dynamic ultrasound to diagnose peroneal tendon instability.

4D Brain Map Uncovers Early Signs of Multiple Sclerosis

New 4D brain map unveils early warning signs and potential therapeutic targets for multiple sclerosis, offering hope for improved treatments.

Study Shows Positive Long-Term Safety of CAR-T Cell Therapy in B Cell Lymphoma

CAR T-cell therapy for B-cell lymphoma shows a positive long-term safety profile with few late complications.

Lifestyle and Environment Have Greater Impact on Health Than Genetics

Environmental and lifestyle factors have a significantly greater influence on health and premature death than genetics according to recent UK study.

Exploring Sword Bean Pods for Allergic Rhinitis Relief

Fine dust, a notable seasonal allergen, exacerbates allergic rhinitis symptoms and contributes to respiratory diseases.

Pomegranate Peel Extract Shows Promise in Treating NAFLD

A clinical trial found that pomegranate peel extract improves liver enzymes, triglycerides, and inflammation markers in NAFLD patients.

Handshake on a green background

Jazz Pharmaceuticals to acquire Chimerix in $935m deal

In a deal worth approximately $935m, Jazz Pharmaceuticals is set to acquire Chimerix, a biotechnology company developing oncology therapies.

Study Debunks Cardiovascular Risk Concerns with Niacinamide

Study finds no increased risk of major cardiovascular events with nicotinamide use but highlights risks for prior MACE patients.